About Ococur
Ococur is a company based in Pune (India) founded in 2016 by Vijay Kanuru. Ococur has raised $27.24 thousand across 1 funding round from investors including Atul Vasantlal Sanghavi and Valentine D'souza. Ococur operates in a competitive market with competitors including Imbed Biosciences, Sirnaomics, Liquidia, Acorda and Genedit, among others.
- Headquarter Pune, India
- Founders Vijay Kanuru
- Stage Minicorn
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Oncocur India Private Limited
- Date of Incorporation 03 May, 2016
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
-$13.24 K (USD)0as on Mar 31, 2017
-
EBITDA
-$12.91 K (USD)0as on Mar 31, 2017
-
Total Equity Funding
$27.24 K (USD)
in 1 rounds
-
Latest Funding Round
$27.24 K (USD), Angel Round
Feb 20, 2020
-
Investors
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ococur
Ococur has successfully raised a total of $27.24K through 1 strategic funding round. The most recent funding activity was a Angel Round of $27.24 thousand completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ococur
Ococur has secured backing from 2 investors, including angel investors. Prominent investors backing the company include Atul Vasantlal Sanghavi and Valentine D'souza.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AV
Atul Vasantlal Sanghavi |
-
|
Locked | Locked | Locked |
|
VD
Valentine D'souza |
-
|
Locked | Locked | Locked |
Investor details for Ococur
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ococur
Investment portfolio details for Ococur
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ococur
Detailed financials for Ococur
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ococur Comparisons
Peer comparison for Ococur
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ococur
Ococur operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imbed Biosciences, Sirnaomics, Liquidia, Acorda and Genedit, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanotech-based wound care products are developed and provided.
|
|
| Locked | Locked | Locked |
RNA-based therapeutics for cancer and fibrosis are developed.
|
|
| Locked | Locked | Locked |
Engineered particles & films for life and material sciences applications
|
|
| Locked | Locked | Locked |
Engaged in the development and commercialization of therapies that improve neurological function.
|
|
| Locked | Locked | Locked |
Genetic medicines are delivered using polymer nanoparticle platforms.
|
|
| Locked | Locked | Locked |
Therapies are developed to target and destroy cancer cells selectively.
|
Detailed competitors of Ococur
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ococur
Complete news archive for Ococur
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ococur
Ococur was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Ococur is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Vijay Kanuru is the current CEO of Ococur. They have also founded this company.
Ococur is a funded company, having raised a total of $27.24K across 1 funding round to date.
Ococur was founded in 2016 in Pune, India, and focuses on nanomedicine for oncology. The MOM platform, utilizing metal oxide-metal nanoparticles, is designed to address drug resistance in cancers through selective cell targeting, barrier penetration via nanometric sizing, non-immunogenic polymer coatings, sustained intracellular drug release, apoptosis induction, lymphocyte recruitment for tumor control, and activation of p53 and related proteins. Operations center on therapeutic development in this sector.
Ococur's top competitors include Imbed Biosciences, Sirnaomics and Arcturus Therapeutics.
Ococur has 2 investors. Key investors include Atul Vasantlal Sanghavi, and Valentine D'souza.
The valuation of Ococur is $3.49M as of Feb 2020.